Diagnosing solvent-induced chronic toxic encephalopathy: the effect of underperformance in neuropsychological testing.
Mestdagh I, van Bergen L, Kocken C, Heyvaert V, Cras P, Van Den Eede F.
Int J Psychiatry Clin Pract. 2019 Sep;23(3):171-177. doi: 10.1080/13651501.2019.1571210. Epub 2019 May 13.
PMID:31082289
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group.
J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z.
PMID:29162153
Neurotoxicity in acute and repeated organophosphate exposure.
Naughton SX, Terry AV Jr.
Toxicology. 2018 Sep 1;408:101-112. doi: 10.1016/j.tox.2018.08.011. Epub 2018 Aug 23.
PMID:30144465
Solvent-related chronic toxic encephalopathy as a target in the worker's mental health research.
Ramos A, Jardim SR, Silva-Filho JF.
An Acad Bras Cienc. 2004 Dec;76(4):757-69. doi: 10.1590/s0001-37652004000400010. Epub 2004 Nov 16.
PMID:15558155
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.